Inhalant Use Disorder
Inhalant use disorder is a psychiatric condition that applies to the deliberate use of inhalants, not to the accidental inhalation of toxic or psychoactive substances, even if they are the same substances that are people inhale when they have inhalant use disorder, and even if they produce identical effects.
Wiki Number: W105
Diagnosis: Inhalant Use Disorder
US Patients: 38 of 50 states make sales of inhalants illegal below age 18
Age Onset: 10-12 years, can be fatal
Brain Area: Individual uses can lower oxygen levels & affect heart rhythms; regular use, harm to brain, heart, kidneys and liver
Symptoms: chemicals whose vapors can be breathed in for intoxication; “sniffing, huffing or bagging”; solvents, gases, medical drugs
Progression: By type: petroleum products, gases, medical anesthetics; abuses vary by product; pregnant users may injure fetuses.
Causes: Hostility to accepted cultural norms
Medications: None listed.
Therapies: None listed.
4 CURRENT ARTICLES
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Sevoflurane administration from extracorporeal membrane oxygenation via the AnaConDa device for a patient with COVID-19: A breakthrough solution for the shortage of intravenous anestheticsby Yudai Iwasaki on July 3, 2022
One of the major issues encountered during the coronavirus disease 2019 (COVID-19) pandemic has been the shortage of intravenous anesthetics. Moreover, patients undergoing extracorporeal membrane oxygenation (ECMO) need large quantities of intravenous anesthetics for sedation. We report the case of a 52-year-old man who was admitted to our hospital due to acute respiratory distress syndrome by COVID-19 and treated with ECMO. As controlling sedation with intravenous anesthetics was challenging,...
- Clinical burden associated with therapies for cardio-pulmonary critical decompensation in preterm neonates across Canadian neonatal intensive care unitsby Ashraf Kharrat on July 2, 2022
CONCLUSIONS: Clustering effects exist in CPCD-associated mortality among Canadian NICUs, with higher incidence units showing lower mortality. These data may aid network-level benchmarking, patient-level risk stratification, parental counseling, and further research and quality improvement work.
- Dry powder inhalers of antitubercular drugsby Nidhi Nainwal on July 2, 2022
Despite advancements in the medical and pharmaceutical fields, tuberculosis remains a major health problem globally. Patients do not widely accept the conventional approach to treating tuberculosis (TB) due to prolonged treatment periods with multiple high doses of drugs and associated side effects. A pulmonary route is a non-invasive approach to delivering drugs, hormones, nucleic acid, steroids, proteins, and peptides directly to the lungs, improving the efficacy of the treatment and...
- Systematic review of the scientific evidence on ethylene oxide as a human carcinogenby Heather Lynch on July 2, 2022
Ethylene oxide is a highly reactive chemical primarily used as an intermediate in chemical production and as a sterilant of medical equipment and food products; it also is produced endogenously as a result of physiological processes. We conducted a systematic review of the potential carcinogenicity of inhaled ethylene oxide in humans using methods that adhere to PRIMSA guidelines and that incorporate aspects from the Institute of Medicine (IOM) of the National Academy of Medicine as well as...